Chen J, Chen S, Zhuo L, Zhu Y, Zheng H. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in Colorectal cancer. Cell Death Dis. 2020;11(3):173. https://doi.org/10.1038/s41419-020-2361-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi C, Kwong DLW, Li X, et al. MAEL augments cancer stemness properties and resistance to sorafenib in hepatocellular carcinoma through the PTGS2/AKT/STAT3 axis. Cancers. 2022;14(12):2880. https://doi.org/10.3390/cancers14122880.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park HR, Choi YJ, Kim JY, Kim IG, Jung U. Repeated irradiation with γ-ray induces cancer stemness through TGF-β-DLX2 signaling in the A549 human Lung cancer cell line. Int J Mol Sci. 2021;22(8):4284. https://doi.org/10.3390/ijms22084284.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Z, Cai L, Lu J, et al. Global expression profile of Tumor stem-like cells isolated from MMQ rat prolactinoma cell. Cancer Cell Int. 2017;17:15. https://doi.org/10.1186/s12935-017-0390-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang R, Dong M, Tu J, et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted Breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct Target Ther. 2023;8(1):97. https://doi.org/10.1038/s41392-023-01337-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agliano A, Calvo A, Box C. The challenge of targeting cancer stem cells to halt Metastasis. Semin Cancer Biol. 2017;44:25–42. https://doi.org/10.1016/j.semcancer.2017.03.003.

Article  CAS  PubMed  Google Scholar 

Tu X, Li C, Sun W, et al. Suppression of cancer cell stemness and drug resistance via MYC destabilization by deubiquitinase USP45 inhibition with a natural small molecule. Cancers. 2023;15(3):930. https://doi.org/10.3390/cancers15030930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of Tumor cells? Cell Stem Cell. 2015;16(3):225–38. https://doi.org/10.1016/j.stem.2015.02.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14(3):275–91. https://doi.org/10.1016/j.stem.2014.02.006.

Article  CAS  PubMed  Google Scholar 

Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328–37. https://doi.org/10.1038/nature12624.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li N, Yu Y, Wang B. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the hedgehog signaling pathway. Am J Physiol Cell Physiol. 2020;319(1):93–104. https://doi.org/10.1152/ajpcell.00133.2019.

Article  CAS  Google Scholar 

Jokela TA, LaBarge MA. Integration of mechanical and ECM microenvironment signals in the determination of cancer stem cell states. Curr stem cell Reports. 2021;7:39–47. https://doi.org/10.1007/s40778-020-00182-2.

Article  Google Scholar 

Mercurio L, Cecchetti S, Ricci A, et al. Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells. PLoS ONE. 2017;12(4):e0176108–8. https://doi.org/10.1371/journal.pone.0176108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tatullo M, Marrelli B, Benincasa C, et al. Organoids in translational oncology. J Clin Med. 2020;9(9):2774. https://doi.org/10.3390/jcm9092774.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oshimori N. Cancer stem cells and their niche in the progression of squamous cell carcinoma. Cancer Sci. 2020;111(11):3985–92. https://doi.org/10.1111/cas.14639.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshida GJ, Saya H. Therapeutic strategies targeting cancer stem cells. Cancer Sci. 2016;107(1):5–11. https://doi.org/10.1111/cas.12817.

Article  CAS  PubMed  Google Scholar 

Oshimori N, Guo Y, Taniguchi S. An emerging role for cellular crosstalk in the cancer stem cell niche. J Pathol. 2021;254(4):384–94. https://doi.org/10.1002/path.5655.

Article  PubMed  PubMed Central  Google Scholar 

Aramini B, Masciale V, Grisendi G, et al. Dissecting Tumor growth: the role of cancer stem cells in drug resistance and recurrence. Cancers. 2022;14(4):976. https://doi.org/10.3390/cancers14040976.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhat V, Allan AL, Raouf A. Role of the microenvironment in regulating normal and cancer stem cell activity: implications for Breast cancer progression and therapy response. Cancers. 2019;11(9):1240. https://doi.org/10.3390/cancers11091240.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang PH, Sekine K, Chao HM, Hsu SH, Chern E. Chitosan promotes cancer progression and stem cell properties in association with wnt signaling in colon and hepatocellular carcinoma cells. Sci Rep. 2017;8:45751. https://doi.org/10.1038/srep45751.

Article  CAS  PubMed  Google Scholar 

Park SY, Lee DG, Jo A, et al. Extracellular microenvironmental change by B16F10 melanoma-derived proteins induces cancer stem-like cell properties from NIH3T3 cells. Sci Rep. 2019;9(1):16757. https://doi.org/10.1038/s41598-019-53326-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dzobo K, Senthebane DA, Rowe A, et al. Cancer stem cell hypothesis for therapeutic innovation in clinical oncology? Taking the root out, not chopping the leaf. OMICS. 2016;20(12):681–91. https://doi.org/10.1089/omi.2016.0152.

Article  CAS  PubMed  Google Scholar 

Atashzar MR, Baharlou R, Karami J, et al. Cancer stem cells: a review from origin to therapeutic implications. J Cell Physiol. 2020;235(2):790–803. https://doi.org/10.1002/jcp.29044.

Article  CAS  PubMed  Google Scholar 

Clarke MF. Clinical and therapeutic implications of cancer stem cells. N Engl J Med. 2019;380(23):2237–45. https://doi.org/10.1056/NEJMra1804280.

Article  CAS  PubMed  Google Scholar 

Kumar VE, Nambiar R, De Souza C, Nguyen A, Chien J, Lam KS. Targeting epigenetic modifiers of Tumor plasticity and cancer stem cell behavior. Cells. 2022;11(9):1403. https://doi.org/10.3390/cells11091403.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aikins ME, Qin Y, Dobson HE, et al. Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in Melanoma. J Control Release off J Control Release Soc. 2022;351:872–82. https://doi.org/10.1016/j.jconrel.2022.09.061.

Article  CAS  Google Scholar 

Lv M, Gong Y, Liu X, et al. CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties. Signal Transduct Target Ther. 2023;8(1):302. https://doi.org/10.1038/s41392-023-01555-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang D, Tang DG, Rycaj K. Cancer stem cells: regulation programs, immunological properties and immunotherapy. Semin Cancer Biol. 2018;52(2):94–106. https://doi.org/10.1016/j.semcancer.2018.05.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang S, Xiang T, Huang S, et al. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in Tumor angiogenesis through autocrine CCL5 signaling. Cancer Lett. 2016;376(1):137–47. https://doi.org/10.1016/j.canlet.2016.03.034.

Article  CAS  PubMed  Google Scholar 

Cheng L, Huang Z, Zhou W, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and Tumor growth. Cell. 2013;153(1):139–52. https://doi.org/10.1016/j.cell.2013.02.021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Auzmendi-Iriarte J, Otaegi-Ugartemendia M, Carrasco-Garcia E, et al. Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity. Cancer Res. 2022;82(7):1283–97. https://doi.org/10.1158/0008-5472.CAN-21-2161.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Wu T, Liu AY, Ouyang G. Differentiation and transdifferentiation potentials of cancer stem cells. Oncotarget. 2015;6(37):39550–63. https://doi.org/10.18632/oncotarget.6098.